Kinetics in hbsag after stopping entecavir or tenofovir in patients with virological relapse but not clinical relapse

HIGHLIGHTS

• who: Tzu-Ning Tseng and colleagues from the Division of Hepatogastroenterology, Department of Internal Medicine, Kaohsiung Chang Gung Memorial have published the Article: Kinetics in HBsAg after Stopping Entecavir or Tenofovir in Patients with Virological Relapse but Not Clinical Relapse, in the Journal: Viruses 2022, 1189 of /2022/
• what: This study investigated the kinetics in and the loss rate after entecavir or tenofovir disoproxil fumarate (TDF) cessation in patients with chronic hepatitis B (CHB) who achieved virological suppression after virological relapse without clinical relapse.
• future: Studies are needed to validate the practicality of . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.